Sprint Corporation (NYSE:S) ended the last trading day at $3.40. Company weekly volatility is calculated as 4.92% and price to cash ratio as 6.50. Sprint Corporation (NYSE:S) showed a weekly performance of -6.08%.
Sprint Corporation (NYSE:S) said that, it will no longer offer subsidized pricing or two-year contracts to new customers. The move comes less than a week after AT&T said it will stop offering contracts. Sprint said back in August it would stop offering contracts by the end of 2015, so it is just a few days behind schedule.
AVX Corp. (NYSE:AVX) ended the last trading day at $10.78. Company weekly volatility is calculated as 3.21% and price to cash ratio as 2.08. AVX Corp. (NYSE:AVX) showed a weekly performance of -11.20%.
AVX Corp. (NYSE:AVX) announced the release of its new T4C series medical grade solid tantalum microchip capacitors. The smallest medical tantalum capacitors available, the T4C series are designed for filtering, hold-up, timing, and pulsing circuits within implantable, non-life-support and non-implantable life support applications.
On 08 January, Amedisys Inc. (NASDAQ:AMED) shares decreased -1.73% and was closed at $38.08. AMED EPS growth in last 5 year was -39.80%. Amedisys Inc. (NASDAQ:AMED) year to date (YTD) performance is -3.15%.
Amedisys Inc. (NASDAQ:AMED) announced that Paul B. Kusserow, President and Chief Executive Officer will present at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 13, 2016.
ClearOne, Inc. (NASDAQ:CLRO) shares decreased -0.33% in last trading session and ended the day at $11.96. CLRO Gross Margin is 63.80% and its has a return on assets of 8.60%. ClearOne, Inc. (NASDAQ:CLRO) quarterly performance is -3.55%.
ClearOne, Inc. (NASDAQ:CLRO) announced that it has been awarded a new patent for acoustic echo cancelation methods.
WAVE Life Sciences Pte. Ltd. (NASDAQ:WVE) caters to the Healthcare space. Its weekly performance is -17.24%. On the last day of trading company shares ended up at $13.20. WAVE Life Sciences Pte. Ltd. (NASDAQ:WVE) distance from 50-day simple moving average (SMA50) is -4.84%.
WAVE Life Sciences Pte. Ltd. (NASDAQ:WVE) is now covered by analysts at Leerink Swann. They set an “outperform” rating and a $20.00 price target on the stock
Leave a Reply